Suppr超能文献

新型1-(氮杂环基)-3-芳基磺酰基-1H-吡咯并[2,3-b]吡啶作为5-HT6激动剂和拮抗剂。

Novel 1-(azacyclyl)-3-arylsulfonyl-1H-pyrrolo[2,3-b]pyridines as 5-HT6 agonists and antagonists.

作者信息

Elokdah Hassan, Li David, McFarlane Geraldine, Bernotas Ronald C, Robichaud Albert J, Magolda Ronald L, Zhang Guo Ming, Smith Deborah, Schechter Lee E

机构信息

Chemical and Screening Sciences, Wyeth Research, 500 Arcola Road, Collegeville, PA 19426, USA.

出版信息

Bioorg Med Chem. 2007 Sep 15;15(18):6208-26. doi: 10.1016/j.bmc.2007.06.024. Epub 2007 Jun 14.

Abstract

1-Aminoethyl-3-arylsulfonyl-1H-indoles 1 are 5-HT(6) receptor ligands with modest activity in a 5-HT(6) cyclase assay. Introduction of an additional nitrogen in the indole ring provides 1-aminoethyl-3-arylsulfonyl-1H-pyrrolo[2,3-b]pyridines 2 with both enhanced 5-HT(6) affinity and cyclase activity, many acting as 5-HT(6) agonists. We constrained the basic side chain as part of a ring to make 1-(azacyclyl)-3-arylsulfonyl-1H-pyrrolo[2,3-b]pyridines incorporating a pyrrolidinyl 3 or piperidinyl 4 ring system. Preparation of compounds 3 and 4 required synthesis of the key intermediates, 1-(pyrrolidin-3-yl)-1H-pyrrolo[2,3-b]pyridines 7 and 1-(piperidin-3-yl)-1H-pyrrolo[2,3-b]pyridines 8, respectively. Intermediates 7 were prepared through alkylation of 7-azaindole while the intermediates 8 required an alternate synthesis. The compounds of both series 3 and 4 were shown to have high binding affinities for the 5-HT(6) receptor. The in vitro functional activity at the 5-HT(6) receptor varied depending on various functionalities including the selection of the arylsulfonyl, the substitution on the arylsulfonyl group, the ring size, and the substitution on the basic amine moiety producing either 5-HT(6) receptor agonists or antagonists.

摘要

1-氨基乙基-3-芳基磺酰基-1H-吲哚1是在5-HT(6)环化酶测定中具有适度活性的5-HT(6)受体配体。在吲哚环中引入额外的氮原子可得到1-氨基乙基-3-芳基磺酰基-1H-吡咯并[2,3-b]吡啶2,其对5-HT(6)的亲和力和环化酶活性均有所增强,许多化合物可作为5-HT(6)激动剂。我们将碱性侧链作为环的一部分进行限制,以制备包含吡咯烷基3或哌啶基4环系统的1-(氮杂环基)-3-芳基磺酰基-1H-吡咯并[2,3-b]吡啶。制备化合物3和4需要分别合成关键中间体1-(吡咯烷-3-基)-1H-吡咯并[2,3-b]吡啶7和1-(哌啶-3-基)-1H-吡咯并[2,3-b]吡啶8。中间体7通过7-氮杂吲哚的烷基化制备,而中间体8则需要另一种合成方法。系列3和4的化合物均显示出对5-HT(6)受体具有高结合亲和力。5-HT(6)受体的体外功能活性因各种官能团而异,包括芳基磺酰基的选择、芳基磺酰基上的取代、环大小以及碱性胺部分上的取代,从而产生5-HT(6)受体激动剂或拮抗剂。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验